Hamburger black

Probiotic Blend

Research Library

This scientific research is for informational use only. The results reported may not necessarily occur in all individuals. Care/of provides this information as a service. This information should not be read to recommend or endorse any specific products.

Probiotics are one of the fastest growing supplements categories in the United States, widely touted for their beneficial gastrointestinal properties. They are found in yogurt, kefir, kombucha, sauerkraut, kimchi, and other foods. Given their recent popularity, more and more foods and drinks are now being fortified with beneficial bacteria. The most popular families of probiotics are Lactobacillus and Bifidobacterium. There are thousands of different strains of probiotics; our probiotic includes two highly studied strains: Bifidobacterium lactis Bl-04, and Lactobacillus acidophilus NCFM. We review some of the findings of these studies below.

Digestion

There are thousands of studies on thousands of different probiotic strains. Here, we focus on studies that review the efficacy of *Bifidobacterium lactis* Bl-04 and *Lactobacillus acidophilus* NCFM.

It has been well established that antibiotics can induce diarrhea and digestive disturbances. A 2009 clinical study gave 40 volunteers a probiotic mixture or a placebo and studied their digestive health during and after antibiotic use. The test revealed that post-antibiotic fecal microbiota in probiotic-consuming subjects were more similar to the baseline microbiota than the control group. This study concludes the probiotics bolster a more rapid return to pre-antibiotic baseline fecal bacterial microbiota. Simply put, probiotics helped people return to normal digestive health after taking antibiotics.

A more recent study was performed on a larger test group of 503 subjects. Patients on antibiotics were given probiotics or a placebo and studied up until 7 days after final antibiotic usage. Between the three groups, 12.5% - 19.6% of probiotic patients experienced antibiotic-associated diarrhea (AAD), while 24.6% of the placebo group struggled with AAD. Another digestive issue, C. difficile-associated disease (CDAD), which is often triggered by antibiotics, was less prevalent in the group taking probiotics. Patients taking probiotics also experienced lower incidence of liquid stools, fever, abdominal pain and bloating.

References
  1. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy.
    Engelbrektson A, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G, Kitts CL.,
    Journal of medical microbiology,
    2009
  2. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study.
    Ouwehand AC, DongLian C, Weijian X, Stewart M, Ni J, Stewart T, Miller LE.,
    Vaccine,
    2014

Immune System

A randomized, double-blind, placebo-controlled study found consumers taking *Bifidobacterium lactis* Bl-04 had experienced lower risk of upper respiratory infection than a placebo group. Another probiotic blend in the study did not show results comparable to *Bifidobacterium lactis* Bl-04.

A pilot study in 2008 examined the effect of seven different probiotic strains on the immune system of 83 healthy adults. They studied immune markers in their subjects and found that the placebo and treatment groups showed similar IgA concentrations However, IgG levels were increased in the subjects taking Bifidobacterium lactis Bl-04 and Lactobacillus acidophilus La-14. Six of the seven strains also showed improvements in immunoglobulin serum concentrations compared with controls.

References
  1. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
    West NP, Horn PL, Pyne DB, Gebski VJ, Lahtinen SJ, Fricker PA, Cripps AW.,
    Clinical nutrition,
    2014
  2. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial.
    Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC.,
    FEMS immunology and medical microbiology,
    2008